New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 21, 2013
09:05 EDTACAD, MOV, YHOO, SCHL, TUMI, PERY, CSCO, ITMN, GES, AZN, ORCLOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Perry Ellis (PERY), up 5.2%... Movado (MOV), up 2.4%... ALSO HIGHER: InterMune (ITMN), up 12.2% after health technology appraisal body in England and Wales recommends use of its Esbriet drug... ACADIA (ACAD), up 7.5% after presenting detailed results from a Phase III study of its treatment for Parkinson's disease psychosis... AstraZeneca (AZN), up 2.8% after saying it plans to restructure its SG&A activities to cut out about 2,300 jobs, announcing partnership agreement with Moderna Therapeutics... Yahoo! (YHOO), up 2% following upgrade at Oppenheimer... DOWN AFTER EARNINGS: Oracle (ORCL), down 7.6%... Guess (GES), down 6%... Tumi (TUMI), down 6%... Scholastic (SCHL), down 11.5%... ALSO LOWER: Cisco (CSCO), down 2.5%, following downgrade at FBR Capital... General Moly (GMO), down 21%, after work suspended on a $665M loan being negotiated for the development of its Mt. Hope Project.
News For ORCL;CSCO;YHOO;AZN;PERY;MOV;GES;TUMI;ACAD;ITMN;SCHL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | all recent news | >>
November 10, 2014
16:00 EDTYHOOOptions Update; November 10, 2014
Subscribe for More Information
15:29 EDTCSCOCisco November volatility increases into Q1 and outlook
Subscribe for More Information
15:26 EDTACADNotable companies reporting after market close
Subscribe for More Information
11:39 EDTYHOOStocks with call strike movement; YHOO NEM
Subscribe for More Information
09:07 EDTPERYPerry Ellis announces luggage partnership with UGA Fashion
Subscribe for More Information
08:22 EDTCSCONetwork equipment makers slip after AT&T projects lower 2015 capital spending
Subscribe for More Information
07:12 EDTCSCOCA Technologies to hold a conference
CA World 2014 is being held in Las Vegas on November 9-12.
November 7, 2014
12:06 EDTYHOOStocks with call strike movement; YHOO CHK
Subscribe for More Information
11:24 EDTYHOOYahoo's small business VP, GM Amit Kumar leaves company, TechCrunch reports
Subscribe for More Information
10:38 EDTSCHLScholastic plans to create new retail space in SoHo
Subscribe for More Information
09:58 EDTCSCOCisco November volatility elevated into Q1 and outlook
Cisco November weekly call option implied volatility is at 40, December is at 21, January is at 19, February is at 20; compared to its 26-week average of 23 according to Track Data, suggesting large near term price movement into the expected release of Q1 results after the market close on November 12.
06:18 EDTYHOOAOL downgraded to Neutral from Buy at Citigroup (yesterday)
Subscribe for More Information
November 6, 2014
16:24 EDTTUMITumi lowers FY14 view to 84c-86c from 88c-92c, consensus 89c
Subscribe for More Information
16:19 EDTTUMITumi reports Q3 EPS 21c, consensus 21c
Subscribe for More Information
14:44 EDTYHOOYahoo price target raised to $53 at BGC Financial citing Alibaba advance
BGC Financial increased its price target on Yahoo (YHOO) to $53 from $50, citing an increased valuation attributable to the company's stake in Alibaba (BABA), whose shares have advanced over 19% since October 22. BGC, which maintains its Buy rating on Yahoo, values the company's stake in Alibaba at $42B, its stake in Yahoo Japan at $7B and the firm continues to value Yahoo's core business at $7B.
06:35 EDTAZNAstraZeneca CEO says tax revisions cripple new Pfizer offer, Reuters says
Subscribe for More Information
05:51 EDTAZNAstraZeneca targets 2015 EPS to be no less than low end of 2014 range
AstraZeneca said, "For 2015, the Company plans to continue to selectively invest in its growth platforms and accelerating pipeline while managing overall costs. Assuming current exchange rates, the Company is targeting Core EPS for 2015 to be no less than the lower end of the range of the upgraded guidance for Core EPS for 2014 at actual exchange rates. Guidance for 2015 is expected to be provided with 2014 results on 5 February 2015."
05:50 EDTAZNAstraZeneca raises 2014 revenue growth outlook to low single digits at CER
AstraZeneca said 2014 revenue is now expected to increase in low single digits at CER, an upgrade to its previous guidance for revenue to be in line with 2013 at CER. The guidance assumes no U.S. Nexium generic in 2014. It added, "In light of the increase in revenue expectations for the year, the Company is accelerating its investments in its growth platforms and expanding pipeline. Core EPS for 2014 is now expected to decrease at around 10% at CER; better than anticipated in previous guidance. In addition, Core EPS for 2014 at actual exchange rates is expected to be impacted negatively by currency by around 5%, assuming current exchange rates."
05:49 EDTAZNAstraZeneca reports Q3 core EPS $1.05, consensus $1.04
Subscribe for More Information
05:37 EDTAZNAegerion acquires Myalept from AstraZeneca for $325M
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | 7 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use